Actively Recruiting
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
Led by Brigham and Women's Hospital · Updated on 2024-09-19
4500
Participants Needed
1
Research Sites
27 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective randomized controlled trial comparing manual review and AI screening for patient eligibility determination and enrollments. A structured query will identify potentially eligible patients from the Mass General Brigham Electronic Data Warehouse (EDW), who will then be randomized into either the manual review arm or the AI-assisted review arm.
CONDITIONS
Official Title
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Documented diagnosis of heart failure (e.g., ICD-9 codes 428 ICD-10 codes I50 or Problem list in the electronic health record)
- Most recent left ventricular ejection fraction (LVEF) assessed within the past 24 months
- Seen Mass General Brigham provider within the last 24 months
You will not qualify if you...
- LVEF <50% currently prescribed or intolerant to an evidence-based beta-blocker, ARNI, MRA, and SGLT2i at least 50% goal dose
- LVEF >50% currently prescribed or intolerant to SGLT2i
- Systolic blood pressure (SBP) <90 mmHg at last measure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
O
Ozan Unlu, MD
CONTACT
A
Alexander J Blood, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here